Ag-Letrozole 2.5 mg (Letrozole TABLET) 2.5 MG

AG-LETROZOLE 2.5 MG tablets are a pharmaceutical product containing letrozole, used for specific medical conditions. This oral medication is manufactured by Angita Pharma Inc. in Canada.

Strength

2.5 MG

Pack Size

Manufacturer / TM Owner

ANGITA PHARMA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AG-LETROZOLE 2.5 MG tablets are commonly used in the management of conditions related to hormone regulation. Letrozole is often prescribed for its effects on estrogen levels, which can be beneficial in certain therapeutic contexts. The primary use of letrozole is to address hormonal imbalances, and it is frequently asked, 'What is letrozole used for?' in discussions about hormone-related treatments.

Side Effects

AG-LETROZOLE 2.5 MG tablets may cause various effects, including changes in hormone levels. Commonly reported effects include hot flashes, fatigue, and joint pain. Individual responses can vary, and it is important to monitor any unusual symptoms while using this medication.

Precautions & Warnings

When handling AG-LETROZOLE 2.5 MG tablets, it is advisable to follow the instructions provided by a healthcare professional. This medication should be stored at room temperature, away from moisture and heat. It is crucial to inform your healthcare provider about any pre-existing conditions or allergies before starting this treatment.

Avoid Interactions

AG-LETROZOLE 2.5 MG tablets may interact with other medications, including those metabolized by the liver. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, alcohol and certain supplements may affect the efficacy of letrozole.

Frequently Asked Questions

AG-LETROZOLE 2.5 MG tablets are used to manage conditions related to hormone regulation, often involving estrogen levels.

AG-LETROZOLE 2.5 MG tablets should be stored at room temperature, away from moisture and heat.

Common effects of AG-LETROZOLE 2.5 MG tablets include hot flashes, fatigue, and joint pain.

AG-LETROZOLE 2.5 MG tablets may interact with other medications, so it is important to consult a healthcare provider.

AG-LETROZOLE 2.5 MG tablets are manufactured by Angita Pharma Inc. in Canada.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.